CUA Online library

Cost savings in prostate cancer treatment: Oral gonadotropin-releasing hormone receptor antagonist is a cost-effective alternative to conventional androgen deprivation therapy
Dr. Rhea Coriaty
Dr. Rhea Coriaty
Affiliations:
null
CUA Online Library. Coriaty R. 06/29/2025; 4172805; MP7.16 Disclosure(s): The authors have no potential conflict of interest
user
Dr. Rhea Coriaty
Affiliations:
null
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies